BridgeBio Pharma, Inc. (FRA:2CL)
Germany
· Delayed Price · Currency is EUR 63.44
+0.84 (1.34%)
At close: Dec 5, 2025
BridgeBio Pharma Employees
As of December 31, 2024, BridgeBio Pharma had 730 total employees, including 725 full-time and 5 part-time employees. The number of employees increased by 174 or 31.29% compared to the previous year.
Employees
730
Change (1Y)
174
Growth (1Y)
31.29%
Revenue / Employee
€414,185
Profits / Employee
€933,219
Market Cap
12.20B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
BridgeBio Pharma News
- 3 days ago - How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint - Investor's Business Daily
- 8 days ago - BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - The Motley Fool
- 10 days ago - BridgeBio to Participate in December Investor Conferences - GlobeNewsWire
- 12 days ago - BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha
- 16 days ago - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Interesting BBIO Put And Call Options For April 2026 - Nasdaq
- 24 days ago - BridgeBio Pharma (BBIO): Wells Fargo Raises Price Target to $84 | BBIO Stock News - GuruFocus
- 25 days ago - BridgeBio Pharma, Inc. (BBIO) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha